CTLA4 and lung carcinoma: BALB/c and C57BL/6 mice were subcutaneously inoculated with 1 × 106 cells of the lung cancer lines ASB-XIV or LLC1, respectively, and then received anti-PD-1, anti-CTLA-4, or a combination of both antibodies.